Abstract
Tinea capitis (ringworm of the head) is the most common dermatophytosis of childhood with an increasing incidence worldwide. If suspected clinically, further diagnostic procedures, including direct microscopy and culture, should be performed. Other scalp alterations, such as seborrheic dermatitis, atopic eczema, psoriasis, alopecia areata, folliculitis, and pseudopelade, may mimic ringworm of the head and must be identified.
A proven fungal infection of scalp skin and hairs warrants immediate initiation of systemic treatment. At present, only oral griseofulvin is approved for therapy of scalp ringworm in children by health authorities. However, the advent of several newer antifungal agents such as itraconazole, fluconazole, and terbinafine has broadened the therapeutic armamentarium in recent years. These agents offer shorter treatment intervals, and their adverse effects and drug interaction profiles appear to be well within acceptable limits.
In patients with tinea capitis, systemic therapy at weight-dependent dosages for an appropriate amount of time in conjunction with topical supportive measures will help to prevent disfiguring hair loss, permanent formation of scar tissue, spread of fungal organisms to other cutaneous regions, and infection of other persons.
Similar content being viewed by others
References
Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol. 2000; 143: 53–8
Creach P, Auffret N, Buot G, et al. Microsporum canis tinea ciliaris and blepharitis. Ann Dermatol Venereol. 1995; 122: 773–4
Khüffner J. Die acht Bücher des hochberühmten Aurelii Cornelii Celssi von beyderley Medicine. Meyntz: J. Schoeffer, 1531
Sabouraud RJA. Maladies du cuir chevelu. II. Les maladies desquamative: pityriasis, et al. opécies pelliculaires. Paris: Masson, 1904
Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000; 42: 1–20
Remak R. De morbo scrofulo. Berlin: Xaverus Hube, 1837
Schoenlein JL. Zur Pathogenese der Impetigines. Arch Anat Physiol Wiss Med 1839,82
Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J. 1999; 18: 180–5
Chmel L. Zoophilic dermatophytes and infection in man. In: Preusser HJ, editor. Medical Mycology. Stuttgart: Fischer, 1980: 61–6
Hurwitz S. Clinical Pediatric Dermatology. 2nd ed. Philadelphia (PA): WB Saunders, 1993
Chang S-E, Kang S-K, Choi J-H, et al. Tinea capitis due to Trichophyton rubrum in a neonate. Pediatr Dermatol. 2002; 19: 356–8
Möhrenschlager M, Seidl HP, Holtmann C, et al. Tinea capitis et corporis due to Microsporum canis in an immunocompromised female adult patient. Mycoses; 2003; 46 Suppl. 1: 19–22
Silverberg NB, Weinberg JM, DeLeo VA. Tinea capitis: focus on African American woman. J Am Acad Dermatol. 2002; 46: S120–4
Fuller LC, Child FC, Higgins EM. Tinea capitis in southeast London: an outbreak of Trichophyton tonsurans infection [letter]. Br J Dermatol. 1997; 136 (1): 139
Hay RJ, Clayton YM, de Silva N, et al. Tinea capitis in south east London: a new pattern of infection with public health implications. Br J Dermatol. 1996; 135 (6): 955–8
Williams JV, Honig PJ, McGinley KJ, et al. Semiquantitative study of tinea capitis and asymptomatic carrier state in inner-city school children. Pediatrics. 1995; 96: 265–7
Möhrenschlager M, Seidl HP, Ginter-Hanselmayer G, et al. Tinea capitis of childhood: incidence and pathogenetic role of Trichophyton tonsurans in Central Europe. J Am Acad Dermatol. 2001; 45 (2): 320–1
Korstanje MJ, Staats CCG. Tinea capitis in northwestern Europe 1963–1993: etiologic agents and their changing prevalence. Int J Dermatol. 1994; 33: 548–9
Lunder M, Lunder M. Is Microsporum canis infection about to become a serious dermatological problem?. Dermatology. 1992; 184: 87–9
Tietz HJ, Ulbricht HM, Sterry W. Tinea capitis in Deutschland: Ergebnisse einer epidemiologischen Analyse. Z Hautkr. 1999; 74: 683–8
Möhrenschlager M, Veltmann V, Seidl HP, et al. Frequency and distribution of dermatophytic infections of childhood. 1991-2000 data from the Department of Dermatology and Allergy Biederstein, Technical University of Munich. JEADV. 2001; 15 Suppl. 2: 219
Marples MJ. The ecology of Microsporum canis Bodin in New Zealand. J Hygiene. 1956; 54: 378–87
Elewski BE, Hay RJ. International summit on cutaneous antifungal therapy, focus on tinea capitis, Boston (MA), Nov 11-13,1994. Pediatr Dermatol. 1996; 13 (1): 69–77
Lee JY, Hsu ML. Pathogenesis of hair infection and black dots in tinea capitis caused by Trichophyton violaceum: a histopathological study. J Cutan Pathol. 1992; 19: 54–8
Möhrenschlager M, Bruckbauer H, Seidl HP, et al. Prevalence of tinea capitis and asymptomatic carriers in preschool children from Augsburg, Germany in 1996: results from the multicentric international study for risk-assessment of indoor and outdoor air pollution on allergy- and eczema morbidity (MIRIAM) [abstract]. Pediatr Dermatol. 2004; 21: 380
Cuétara MS, del Palacio M, Noriega AR, et al. Prevalence of undetected tinea capitis in a prospective school survey in Madrid: emergence of new causative fungi. Br J Dermatol. 1998; 138: 658–60
Sharma V, Hall JC, Knapp JF, et al. Scalp colonization by Trichophyton tonsurans in a urban pediatric clinic. Arch Dermatol. 1988; 124: 1511–3
Hay RJ, Robles W, Midgley D, et al. Tinea capitis in Europe: new perspectives on an old problem. J Fur Acad Dermato. 2001; 15: 229–33
Leeming JG, Elliott TSJ. The emergence of Trichophyton tonsurans tinea capitis in Birmingham, UK. Br J Dermatol. 1995; 133: 929–31
Buckley DM, Moss C, Austin G, et al. Trichophyton tonsurans infection in Birmingham [abstract]. Br J Dermatol. 1996; 135 Suppl. 47: 21
Fuller LC, Child FJ, Midgley G, et al. Diagnosis and management of scalp ringworm. BMJ. 2003; 326: 539–41
McGinnis MR, Tilton RC. Dermatophytes. In: Howard BJ, editor. Clinical and pathogenic microbiology. 2nd ed. St Louis (MO): Mosby-Year Book, 1993: 587–95
Gupta AK, Hofstader SL, Adam P, et al. Tinea capitis: an overview on management. Pediatr Dermatol. 1999; 16: 171–89
Bode U, Dorn M, Ring J. Kerion Celsi. Fortschr Med. 1980; 98: 1348–50
Hebert AA. Tinea capitis: current concepts. Arch Dermatol. 1988; 124: 1554–7
Sharma V, Silverberg NB, Howard R, et al. Do hair care practices affect the acquisition of tinea capitis?. Arch Pediatr Adolesc Med. 2001; 155: 818–21
Babel DE, Baughman SA. Evaluation of the adult carrier state in juvenile tinea capitis. J Am Acad Dermatol. 1989; 21: 1209–12
Honig PJ, Caputo GL, Leyden JJ, et al. Microbiology of kerion. J Pediatr. 1993; 123: 422–4
Abeck D. Tinea capitis. In: Abeck D, Burgdorf W, Cremer H, editors. Common skin diseases in children. Darmstadt: Steinkopff, 2003: 115–9
Möhrenschlager M, Abeck D. Dermatologische Mykologie. In: Köhn FM, Ring J, editors. Fallstricke and Fehlerquellen in der Dermatologie. Wien: Springer, 2003: 122–31
Taplin D, Zaias N, Rebell G, et al. Isolation and recognition of dermatophytes on a new medium (DTM). Arch Dermatol. 1969; 99: 203–9
Silverman RA, Elewski BE. Cutaneous fungal infections. 2nd ed. Malden (MA): Blackwell Science, 1998: 261–85
De Hoog GS, Guarro J, Gene J, et al. Atlas of clinical fungi. 2nd ed. Utrecht: Centraalbureau voor Schimmelcultures/Reus: Universitat Rovira i Virgili, 2000
Kefalidou S, Odia S, Gruseck E, et al. Wood’s light in Microsporum canis positive patients. Mycoses. 1997; 40: 461–3
Elewski BE. Cutaneous mycoses in children. Br J Dermatol. 1996; 134 Suppl. 46: 7–11
Dostrovsky A. Campaign against contagious diseases in Palestine. Hahinuch. 1925; 2: 96–103
Gupta AK, Sander DN, Shear NH. Antifungal agents: an overview. J Am Acad Dermatol. 1994; 30: 677–98
Möhrenschlager M, Korting HC, Seidl HP, et al. Tinea capitis. Hautarzt. 2002; 53: 788–94
Sheretz E. Are laboratory studies necessary for griseofulvin therapy? [letter]. J Am Acad Dermatol. 1990; 22: 1103
Abeck D, Möhrenschlager M. Tinea capitis: ein ungelöstes Problem. In: Plewig G, Prinz J, editors. Fortschritte der praktischen Dermatologie and Venerologie 2002. Berlin: Springer, 2003: 463–6
Möhrenschlager M, Schnopp C, Fesq H, et al. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole. Br J Dermatol. 2000; 143: 1011–5
Solomon BA, Collins R, Sherma R, et al. Fluconazole in the treatment of tinea capitis in children. J Am Acad Dermatol. 1997; 37 (2 Pt 1): 274–5
Haria M, Bryson HM, Goa KL. Itraconazole. Drugs. 1996; 51: 585–620
Blumer JL. Pharmacologic basis for the treatment of tinea capitis. Pediatr Infect Dis J. 1999; 18: 191–9
Dastghaib L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: griseofulvin versus Fuconazole. J Derm Treat. 2005; 16: 43–6
Koumantaki E, Kakourou T, Rallis E, et al. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol. 2001; 18: 339–42
Conjeevaram G, Vonghtavaravat V, Sumner R, et al. Terbinafine-induced hepatitis and pancytopenia. Dig Dis Sci. 2001; 46: 1714–6
Friedlander SF. Terbinafine dose and complete cure rate in tinea capitis [abstract]. JEADV. 2002; 16 Suppl. 1: 242
Committee on Infectious Diseases. Tinea capitis. In: Peter G, editor. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Chicago (IL): American Academy of Pediatrics, 1997: 523–5
Hussain I, Muzzaffar F, Rashid T, et al. A randomized comparative trial of treatment of kerion Celsi with griseofulvin plus oral prednisolone vs griseofulvin alone. Med Mycol. 1999; 37: 97–9
Honig PJ, Caputo GL, Leyden JJ, et al. Treatment of kerions. Pediatr Dermatol. 1994; 11: 69–71
Keipert JA. Beneficial effect of corticosteroid therapy in Microsporum canis kerion. Aust J Dermatol. 1984; 25: 127–30
Allen HB, Honig PJ, Leyden JJ, et al. Selenium sulphide: adjunctive therapy for tinea capitis. Pediatrics. 1982; 69: 81–3
Neil G, Hanslo D. Control of the carrier state of scalp dermatophytes. Pediatr Inf Dis J. 1990; 9: 57–8
Midgley G, Clayton YM. Distribution of dermatophytes and candida spores in the environment. Br J Dermatol. 1972; 86: 69–77
Mancianti F, Pedonese F, Zullino C. Efficacy of oral administration of itraconazole to cats with dermatophytosis caused by Microsporum canis. J Am Vet Med Assoc. 1998; 213: 993–5
Fenner A. Dermatophyten-Impfstoffe in der Veterindrmedizin [abstract]. Mycoses. 2002; 45: 222
McKenzie DWR. Hairbrush diagnosis in detection and eradication of non-fluorescent scalp ringworm. BMJ; 1963; 10: 363–5
Acknowledgments
The authors received unrestricted financial grants and/or participated in clinical trials by Pfizer, Novartis, and Janssen. The professional assistance of Mrs Marga Mittermaier in preparing the mycological specimens is highly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Möhrenschlager, M., Seidl, H.P., Ring, J. et al. Pediatric Tinea Capitis. Am J Clin Dermatol 6, 203–213 (2005). https://doi.org/10.2165/00128071-200506040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200506040-00001